The U.S. Food and Drug Administration (FDA) has granted premarket notification clearance for two catheters invented by Riyaz Bashir, MD, FACC, RVT and Nicholas Green. Thrombolex is a company founded in partnership with Temple University to develop these catheter-based clot dissolving devices.